Tumor-specific antibody cocktail treatment suppresses colorectal tumor growth in mice
Our findings establish a proof-of-concept for individualized, mutation-guided antibody therapies, supporting further development of this approach to improve outcomes in patients with advanced CRC.
Authors
- Stephanie C. Pero
- Yujing Sun (ORCID: https://orcid.org/0000-0002-5211-2974)
- David N. Krag (ORCID: https://orcid.org/0000-0001-5355-5999)
- Linda Mei
- Girja S. Shukla
- Margaret E. Ackerman
- Matthew R. Fournier
Institutions
- Dartmouth College (US)
- University of Vermont (US)
- Shelburne Museum (US)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1007/s00262-026-04337-8
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00